谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Pembrolizumab with or Without Lenvatinib As First-line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC): Phase 3 LEAP-010 Study

L. Licitra,M. Tahara,K. Harrington,M. Olivera Hurtado de Mendoza,Y. Guo,S. Aksoy,M. Fang,B. Zurawski,T. Csoszi,M. Klochikhin,T. B. de Oliveira, S. Takahashi,M. H. Yang,P. L. Swiecicki, K. O'Hara, J. Shen, A. Wang,B. Gumuscu, K. Benjamin,R. I. Haddad

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS（2024）

引用 0|浏览16
暂无评分
关键词
PD-1 and PD-L1,Treatment Guidelines
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要